Kevin Douglas has deep experience representing public companies on corporate and securities laws related matters, including companies within the healthcare industry. Kevin’s public company practice focuses on corporate governance matters, securities laws compliance, mergers and acquisitions, corporate finance and shareholder activism. His representative experience has ranged from providing SEC disclosure advice to the audit committee of a Fortune 100 company to representing an NYSE-listed company in connection with its $4.3 billion acquisition by another public company to representing another NYSE-listed company in connection with its issuance of $2.2 billion in senior notes. Kevin has also represented private companies in a wide variety of mergers and acquisition, corporate finance, and other corporate law matters. Kevin served as chair of the Corporate & Securities Practice Group from 2018-2021.
Engaged in 2010 to serve as independent disclosure counsel to the Audit Committee of the Board of Directors of Bank of America pursuant to a settlement order entered into by Bank of America and the SEC
American Bar Association
American Health Law Association (AHLA)
Engaged in 2010 to serve as independent disclosure counsel to the Audit Committee of the Board of Directors of Bank of America pursuant to a settlement order entered into by Bank of America and the SEC
We represented Dean Solon, the founder of Shoals Technologies Group, Inc. (backed by Oaktree Capital), a leading solar-power components maker, in connection with Shoals’ initial public offering (IPO) of 88.5 million shares of Class A common stock for a total net proceeds of more than $2.2 billion. The shares began trading on the Nasdaq Global Market under the symbol “SHLS” on January 27, 2021. Bass Berry & Sims has represented Shoals since the 2016 recapitalization transaction with Oaktree Capital.
We represented HealthStream (Nasdaq: HSTM), a leading provider of workforce and provider solutions for the healthcare industry, in its $67.5 million cash acquisition of Change Healthcare’s staff scheduling business, which includes ANSOS™ Staff Scheduling application and related products. Together, ANSOS with recent acquisitions, ShiftWizard and NurseGrid, will represent HealthStream’s portfolio of nurse and staff scheduling solutions and helps establish them as the market leader in healthcare workforce scheduling business.
Representation of Forcura, LLC, a healthcare technology that facilitates continuity of care, in its sale to Accel-KKR, a Silicon Valley-based technology-focused private equity firm
Represented Addus HomeCare Corporation (Nasdaq: ADUS) in four strategic acquisitions and in its underwritten public offering of 2.3 million shares of common stock in 2019.
Represented Pace Payment Systems, Inc. in its sale to i3 Verticals, Inc. for $52.7 million
Represented Engility Holdings in its merger with Science Applications International Corp. in which SAIC acquired Engility in an all-stock transaction valued at $2.5 billion
Representation of Change Healthcare in its strategic investment for a minority position in MDsave, a technology and healthcare payments company that simplifies the healthcare services shopping and payment experience for consumers
Addus Homecare August 2018 Common Stock Offering
Represented i3 Verticals, Inc. in its initial public offering (IPO) of 7,647,500 shares of Class A common stock for a total net proceeds of $92.5 million.
Represented Change Healthcare in its acquisition of National Decision Support Company
The Best Lawyers in America© — Corporate Law (2013-2023)
IFLR1000 — Notable Practitioner (2019-2021)
Vanderbilt Law Review — Member (1996-1998)